Elixia Central Florida — Orlando, Florida

Elixia Central Florida is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Elixia Central Florida has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease, Atherosclerotic Cardiovascular Disease in Patients With ESKD.

Sponsors: CSL Behring, Bayer.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Elixia Central Florida?

Elixia Central Florida has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Elixia Central Florida conducted?

Elixia Central Florida has 3 clinical trials on record, with 2 currently active. Their work covers Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease, Atherosclerotic Cardiovascular Disease in Patients With ESKD.

Is Elixia Central Florida accredited by Crixeo Health?

Elixia Central Florida has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Elixia Central Florida?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.